ACP-204

· ACADIA Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ACP-204, covering 2026-04-07 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis [Phase 3]